The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease
Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in Parkinson's disease has not yet been elucidated. This study used a new magnetic resonance imaging contrast, quantitative susceptib...
Saved in:
Published in | Brain (London, England : 1878) Vol. 140; no. 1; pp. 118 - 131 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.01.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0006-8950 1460-2156 |
DOI | 10.1093/brain/aww278 |
Cover
Abstract | Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in Parkinson's disease has not yet been elucidated. This study used a new magnetic resonance imaging contrast, quantitative susceptibility mapping, and state-of-the-art methods to map for the first time the whole-brain landscape of magnetostatic alterations as a surrogate for iron level changes in n = 25 patients with idiopathic Parkinson's disease versus n = 50 matched controls. In addition to whole-brain analysis, a regional study including sub-segmentation of the substantia nigra into dorsal and ventral regions and qualitative assessment of susceptibility maps in single subjects were also performed. The most remarkable basal ganglia effect was an apparent magnetic susceptibility increase-consistent with iron deposition-in the dorsal substantia nigra, though an effect was also observed in ventral regions. Increased bulk susceptibility, additionally, was detected in rostral pontine areas and in a cortical pattern tightly concordant with known Parkinson's disease distributions of α-synuclein pathology. In contrast, the normally iron-rich cerebellar dentate nucleus returned a susceptibility reduction suggesting decreased iron content. These results are in agreement with previous post-mortem studies in which iron content was evaluated in specific regions of interest; however, extensive neocortical and cerebellar changes constitute a far more complex pattern of iron dysregulation than was anticipated. Such findings also stand in stark contrast to the lack of statistically significant group change using conventional magnetic resonance imaging methods namely voxel-based morphometry, cortical thickness analysis, subcortical volumetry and tract-based diffusion tensor analysis; confirming the potential of whole-brain quantitative susceptibility mapping as an in vivo biomarker in Parkinson's disease. |
---|---|
AbstractList | Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in Parkinson's disease has not yet been elucidated. This study used a new magnetic resonance imaging contrast, quantitative susceptibility mapping, and state-of-the-art methods to map for the first time the whole-brain landscape of magnetostatic alterations as a surrogate for iron level changes in n = 25 patients with idiopathic Parkinson's disease versus n = 50 matched controls. In addition to whole-brain analysis, a regional study including sub-segmentation of the substantia nigra into dorsal and ventral regions and qualitative assessment of susceptibility maps in single subjects were also performed. The most remarkable basal ganglia effect was an apparent magnetic susceptibility increase-consistent with iron deposition-in the dorsal substantia nigra, though an effect was also observed in ventral regions. Increased bulk susceptibility, additionally, was detected in rostral pontine areas and in a cortical pattern tightly concordant with known Parkinson's disease distributions of α-synuclein pathology. In contrast, the normally iron-rich cerebellar dentate nucleus returned a susceptibility reduction suggesting decreased iron content. These results are in agreement with previous post-mortem studies in which iron content was evaluated in specific regions of interest; however, extensive neocortical and cerebellar changes constitute a far more complex pattern of iron dysregulation than was anticipated. Such findings also stand in stark contrast to the lack of statistically significant group change using conventional magnetic resonance imaging methods namely voxel-based morphometry, cortical thickness analysis, subcortical volumetry and tract-based diffusion tensor analysis; confirming the potential of whole-brain quantitative susceptibility mapping as an in vivo biomarker in Parkinson's disease. |
Author | Cardenas-Blanco, Arturo Butryn, Michaela Nestor, Peter J. Valdes-Herrera, Jose P. Galazky, Imke Acosta-Cabronero, Julio Betts, Matthew J. |
Author_xml | – sequence: 1 givenname: Julio surname: Acosta-Cabronero fullname: Acosta-Cabronero, Julio – sequence: 2 givenname: Arturo surname: Cardenas-Blanco fullname: Cardenas-Blanco, Arturo – sequence: 3 givenname: Matthew J. surname: Betts fullname: Betts, Matthew J. – sequence: 4 givenname: Michaela surname: Butryn fullname: Butryn, Michaela – sequence: 5 givenname: Jose P. surname: Valdes-Herrera fullname: Valdes-Herrera, Jose P. – sequence: 6 givenname: Imke surname: Galazky fullname: Galazky, Imke – sequence: 7 givenname: Peter J. surname: Nestor fullname: Nestor, Peter J. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27836833$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0LtOwzAUgGELFdELbMwoIwOhPnHiOCOquEmVYCgDU2Qnp9SQOsF2VHXjNXg9noT0AgNiso70nSPrH5KeqQ0Scgr0EmjGxspKbcZytYpScUAGEHMaRpDwHhlQSnkosoT2ydC5V0ohZhE_Iv2OMi4YG5Dn2QKD1aKuMNweChrpPVoT1PNgKV8Mel0ErnUFNl4rXWm_Dhq0vrVKel0bF3Q7j9K-aeNq8_Xx6YJSO5QOj8nhXFYOT_bviDzdXM8md-H04fZ-cjUNC5YlPhQ8S1UslBCIvGBplILKKKelKlWaIkeIEkxFKpWKSlAiSRJQMQBE3aAKYCNyvrvb2Pq9Refzpe6-W1XSYN26HATLABLGNvRsT1u1xDJvrF5Ku85_cnTgYgcKWztncf5LgOab2vk2Ur6r3fHoDy-032bxHav-X_oG1oWHZQ |
CitedBy_id | crossref_primary_10_1002_nbm_4292 crossref_primary_10_1007_s11684_019_0725_5 crossref_primary_10_1016_j_nicl_2018_07_028 crossref_primary_10_1016_j_fct_2019_05_038 crossref_primary_10_1111_jon_12957 crossref_primary_10_1007_s00429_022_02547_1 crossref_primary_10_1016_j_clineuro_2020_106181 crossref_primary_10_3389_fendo_2022_844351 crossref_primary_10_1016_j_banm_2019_04_019 crossref_primary_10_1016_j_neuroimage_2019_03_060 crossref_primary_10_1002_nbm_4571 crossref_primary_10_1002_mrm_28185 crossref_primary_10_3389_fnins_2023_1165446 crossref_primary_10_1002_mrm_29958 crossref_primary_10_1142_S0219519421400261 crossref_primary_10_1002_jmri_25693 crossref_primary_10_1038_s41531_024_00758_3 crossref_primary_10_1007_s00702_017_1695_x crossref_primary_10_1002_mds_29123 crossref_primary_10_1097_WCO_0000000000000463 crossref_primary_10_1097_WCO_0000000000000584 crossref_primary_10_1186_s12868_017_0369_9 crossref_primary_10_3389_fnins_2021_618435 crossref_primary_10_1016_j_neuroimage_2024_120583 crossref_primary_10_3348_jksr_2022_0044 crossref_primary_10_1016_j_nicl_2021_102831 crossref_primary_10_1007_s00234_017_1813_3 crossref_primary_10_1109_TMI_2023_3305378 crossref_primary_10_1016_j_media_2024_103173 crossref_primary_10_1111_bpa_13288 crossref_primary_10_1002_mds_27730 crossref_primary_10_1002_nbm_4272 crossref_primary_10_1002_ana_25376 crossref_primary_10_1016_j_ejmp_2022_09_012 crossref_primary_10_1038_s41467_024_49949_9 crossref_primary_10_1016_j_neuroimage_2019_116018 crossref_primary_10_1016_j_radi_2025_102903 crossref_primary_10_1186_s13195_020_00612_7 crossref_primary_10_3389_fncir_2019_00050 crossref_primary_10_1002_mds_27929 crossref_primary_10_1016_j_neuroimage_2018_07_065 crossref_primary_10_1002_mrm_29218 crossref_primary_10_1002_mds_29702 crossref_primary_10_1016_j_media_2024_103160 crossref_primary_10_1016_j_neuroimage_2018_04_047 crossref_primary_10_1016_j_zemedi_2021_06_004 crossref_primary_10_3390_ph15050551 crossref_primary_10_1097_CM9_0000000000003167 crossref_primary_10_1093_sleep_zsab131 crossref_primary_10_1007_s00330_023_10283_1 crossref_primary_10_2463_mrms_tn_2018_0066 crossref_primary_10_1002_jmri_26161 crossref_primary_10_1093_brain_awab084 crossref_primary_10_1016_j_neuroimage_2019_05_004 crossref_primary_10_1111_ene_15447 crossref_primary_10_1002_jmri_26279 crossref_primary_10_1016_j_neuroimage_2022_119410 crossref_primary_10_1109_TVCG_2021_3137174 crossref_primary_10_1002_mrm_29048 crossref_primary_10_3389_fnagi_2020_610962 crossref_primary_10_1016_j_lfs_2023_121508 crossref_primary_10_1016_j_nicl_2024_103577 crossref_primary_10_1016_j_nicl_2019_101999 crossref_primary_10_1097_MD_0000000000021403 crossref_primary_10_1093_brain_awy211 crossref_primary_10_1016_j_nicl_2023_103394 crossref_primary_10_3988_jcn_2018_14_1_90 crossref_primary_10_1016_j_zemedi_2022_08_001 crossref_primary_10_1148_radiol_2021203341 crossref_primary_10_1002_hbm_25556 crossref_primary_10_1093_brain_awx245 crossref_primary_10_12677_ACM_2022_126738 crossref_primary_10_1002_jmri_26984 crossref_primary_10_1148_radiol_2018180112 crossref_primary_10_1002_jmri_29698 crossref_primary_10_1016_j_neuroimage_2022_119842 crossref_primary_10_1007_s00330_023_09411_8 crossref_primary_10_1109_TMI_2023_3294182 crossref_primary_10_3389_fnagi_2025_1504733 crossref_primary_10_1007_s00702_020_02271_2 crossref_primary_10_1016_j_nicl_2022_102989 crossref_primary_10_1007_s00330_018_5419_x crossref_primary_10_1136_jnnp_2019_322042 crossref_primary_10_3389_fnins_2022_938092 crossref_primary_10_1016_j_neuroimage_2017_09_042 crossref_primary_10_1259_bjr_20210809 crossref_primary_10_1002_mds_27705 crossref_primary_10_1002_mds_28077 crossref_primary_10_1016_j_parkreldis_2018_07_011 crossref_primary_10_1016_j_neurobiolaging_2018_11_013 crossref_primary_10_1016_j_neuroimage_2023_120148 crossref_primary_10_1016_j_compeleceng_2021_107091 crossref_primary_10_1016_j_neuroimage_2024_120547 crossref_primary_10_1007_s10534_018_0131_5 crossref_primary_10_1007_s00330_022_08790_8 crossref_primary_10_1021_acschemneuro_7b00247 crossref_primary_10_3389_fneur_2020_572976 crossref_primary_10_3389_fneur_2024_1407860 crossref_primary_10_1007_s00702_019_02138_1 crossref_primary_10_1002_hbm_26675 crossref_primary_10_1016_j_freeradbiomed_2023_12_005 crossref_primary_10_1111_ejn_14756 crossref_primary_10_3389_fneur_2021_631210 crossref_primary_10_1002_jmri_29569 crossref_primary_10_1016_j_nicl_2021_102637 crossref_primary_10_3389_fnagi_2022_909552 crossref_primary_10_1016_j_neuroimage_2021_118404 crossref_primary_10_1016_j_pnpbp_2023_110903 crossref_primary_10_1016_j_praneu_2019_01_008 crossref_primary_10_30773_pi_2022_0110 crossref_primary_10_1002_nbm_3798 crossref_primary_10_1016_j_nicl_2020_102185 crossref_primary_10_18632_aging_202368 crossref_primary_10_1038_s41582_022_00618_9 crossref_primary_10_1093_brain_awaa089 crossref_primary_10_1002_hbm_25770 crossref_primary_10_1016_j_mri_2018_06_006 crossref_primary_10_1186_s12868_019_0505_9 crossref_primary_10_1016_j_neuroimage_2024_120892 crossref_primary_10_3233_JPD_212833 crossref_primary_10_1016_j_neuroimage_2022_119503 crossref_primary_10_1111_ene_15754 crossref_primary_10_1002_mp_17747 crossref_primary_10_1016_j_bspc_2024_107446 crossref_primary_10_3389_fncel_2022_1005182 crossref_primary_10_1002_nbm_4517 crossref_primary_10_1007_s13538_022_01098_4 crossref_primary_10_1016_j_neuroimage_2021_118574 crossref_primary_10_1016_j_mri_2018_04_004 crossref_primary_10_1002_hbm_26178 crossref_primary_10_1007_s00702_024_02856_1 crossref_primary_10_1007_s12264_017_0138_x crossref_primary_10_1002_nbm_4461 crossref_primary_10_1016_j_dadm_2019_04_010 crossref_primary_10_1038_s41531_022_00347_2 crossref_primary_10_1002_mds_27717 crossref_primary_10_1007_s40263_019_00668_6 crossref_primary_10_3174_ajnr_A7822 crossref_primary_10_1016_j_mri_2018_10_001 crossref_primary_10_1093_braincomms_fcab306 crossref_primary_10_3389_fnagi_2019_00106 crossref_primary_10_3389_fnins_2021_647168 crossref_primary_10_1016_j_ibneur_2025_01_003 crossref_primary_10_1007_s00115_017_0289_z crossref_primary_10_1002_mds_27275 crossref_primary_10_1093_brain_awab274 crossref_primary_10_1002_mrm_27509 |
Cites_doi | 10.1007/s00702-012-0873-0 10.1002/ana.22592 10.1093/brain/awl388 10.1016/j.jns.2012.11.009 10.1371/journal.pone.0112638 10.1016/j.neuroimage.2012.05.049 10.1093/brain/114.5.2283 10.1016/j.neuroimage.2011.02.046 10.1016/S0197-4580(02)00065-9 10.1155/2014/581256 10.1016/j.neurobiolaging.2013.09.034 10.1002/mds.26043 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G 10.1093/brain/aww022 10.1212/WNL.0b013e31829e6fd2 10.1007/s00702-012-0898-4 10.1111/j.1471-4159.1991.tb02017.x 10.1016/j.neuroimage.2008.03.061 10.1093/brain/114.4.1953 10.1038/334345a0 10.1148/radiology.172.2.2748838 10.1212/01.wnl.0000262033.01945.9a 10.1111/j.1552-6569.2008.00246.x 10.1016/j.neuroimage.2010.10.070 10.1111/j.1471-4159.1958.tb12607.x 10.1093/brain/122.4.667 10.1111/j.1471-4159.2010.07132.x 10.3174/ajnr.A4260 10.1016/j.neuroimage.2013.04.022 10.1093/brain/awv361 10.1136/jnnp.55.3.181 10.1016/j.neuroimage.2014.11.010 10.1002/nbm.3489 10.1093/brain/122.8.1437 10.1111/j.1471-4159.1989.tb09150.x 10.1002/nbm.3554 10.1523/JNEUROSCI.20-16-06048.2000 10.1016/j.tics.2013.03.003 10.1016/0006-8993(92)91334-B 10.1016/S1474-4422(14)70117-6 10.1016/j.neuroimage.2016.05.024 10.1073/pnas.0911177107 10.1007/s12640-010-9187-x 10.1016/j.jtemb.2013.09.006 10.3389/fnins.2012.00171 10.1371/journal.pone.0112512 10.1002/mrm.24272 10.1212/01.wnl.0000286384.31050.b5 10.1523/JNEUROSCI.1907-15.2016 10.1093/brain/aws360 10.1016/0022-3956(75)90026-6 10.1002/hbm.22928 10.1016/S0140-6736(14)60357-3 10.1016/j.neuroimage.2014.02.026 10.1002/mrm.10171 10.1016/j.neuroimage.2014.01.060 10.1093/brain/awv136 10.1016/j.neuroimage.2006.02.024 10.1364/OL.28.001194 10.1007/s00441-004-0956-9 10.1371/journal.pone.0035397 10.1088/0031-9155/54/3/012 10.1016/j.mri.2015.02.021 10.1002/ana.1133 |
ContentType | Journal Article |
Copyright | The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1093/brain/aww278 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2156 |
EndPage | 131 |
ExternalDocumentID | 27836833 10_1093_brain_aww278 |
Genre | Journal Article |
GroupedDBID | --- -E4 -~X .2P .55 .GJ .I3 .XZ .ZR 0R~ 1CY 1TH 23N 2WC 354 3O- 4.4 41~ 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6PF 70D AABZA AACZT AAGKA AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT AAWTL AAYJJ AAYXX ABDFA ABDPE ABEJV ABEUO ABGNP ABIME ABIVO ABIXL ABJNI ABKDP ABLJU ABMNT ABNGD ABNHQ ABNKS ABPIB ABPQP ABPTD ABQLI ABQNK ABSMQ ABVGC ABWST ABXVV ABXZS ABZBJ ABZEO ACBNA ACFRR ACGFS ACIWK ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFGWE AFIYH AFOFC AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGORE AGQPQ AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AI. AIJHB AJBYB AJDVS AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BR6 BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE CITATION COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBS EE~ EIHJH EJD ELUNK EMOBN ENERS F5P F9B FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MBLQV MBTAY MHKGH ML0 MVM N4W N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBFPC OBOKY OCZFY ODMLO OHH OHT OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCN TCURE TEORI TJX TLC TMA TR2 VH1 VVN W8F WH7 WOQ X7H X7M XJT XOL YAYTL YKOAZ YQJ YSK YXANX ZCG ZGI ZKB ZKX ZXP ~91 ABQTQ CGR CUY CVF ECM EIF M49 NPM 7X8 |
ID | FETCH-LOGICAL-c395t-8697b48b88ee6c37271b9060dbdb77e6e125e787abb2d1b85551b411121b8bc13 |
ISSN | 0006-8950 |
IngestDate | Sat Sep 27 16:55:11 EDT 2025 Thu Apr 03 06:59:02 EDT 2025 Tue Jul 01 00:46:08 EDT 2025 Thu Apr 24 22:51:19 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | movement disorders cellular mechanisms biomarkers Parkinson’s disease oxidative stress |
Language | English |
License | The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c395t-8697b48b88ee6c37271b9060dbdb77e6e125e787abb2d1b85551b411121b8bc13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/brain/article-pdf/140/1/118/23001949/aww278.pdf |
PMID | 27836833 |
PQID | 1839115331 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_1839115331 pubmed_primary_27836833 crossref_primary_10_1093_brain_aww278 crossref_citationtrail_10_1093_brain_aww278 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-01-01 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Brain (London, England : 1878) |
PublicationTitleAlternate | Brain |
PublicationYear | 2017 |
References | 2016122800401139000_140.1.118.29 2016122800401139000_140.1.118.28 2016122800401139000_140.1.118.26 2016122800401139000_140.1.118.24 Hare (2016122800401139000_140.1.118.25) 2012; 119 He (2016122800401139000_140.1.118.27) 2015; 36 2016122800401139000_140.1.118.22 2016122800401139000_140.1.118.21 2016122800401139000_140.1.118.65 2016122800401139000_140.1.118.64 2016122800401139000_140.1.118.63 2016122800401139000_140.1.118.62 2016122800401139000_140.1.118.61 2016122800401139000_140.1.118.60 2016122800401139000_140.1.118.39 Kim (2016122800401139000_140.1.118.31) 2014; 9 2016122800401139000_140.1.118.38 2016122800401139000_140.1.118.37 2016122800401139000_140.1.118.35 2016122800401139000_140.1.118.34 Schwarz (2016122800401139000_140.1.118.51) 2014; 383 2016122800401139000_140.1.118.33 2016122800401139000_140.1.118.32 2016122800401139000_140.1.118.30 2016122800401139000_140.1.118.49 2016122800401139000_140.1.118.48 2016122800401139000_140.1.118.47 2016122800401139000_140.1.118.46 2016122800401139000_140.1.118.45 Han (2016122800401139000_140.1.118.23) 2013; 325 Ostrerova-Golts (2016122800401139000_140.1.118.44) 2000; 20 2016122800401139000_140.1.118.43 2016122800401139000_140.1.118.42 2016122800401139000_140.1.118.41 2016122800401139000_140.1.118.40 2016122800401139000_140.1.118.6 2016122800401139000_140.1.118.19 2016122800401139000_140.1.118.5 2016122800401139000_140.1.118.18 2016122800401139000_140.1.118.17 2016122800401139000_140.1.118.3 2016122800401139000_140.1.118.16 2016122800401139000_140.1.118.15 2016122800401139000_140.1.118.59 2016122800401139000_140.1.118.1 2016122800401139000_140.1.118.14 2016122800401139000_140.1.118.58 2016122800401139000_140.1.118.13 2016122800401139000_140.1.118.57 2016122800401139000_140.1.118.12 2016122800401139000_140.1.118.56 2016122800401139000_140.1.118.8 2016122800401139000_140.1.118.7 Lehericy (2016122800401139000_140.1.118.36) 2014; 29 Groeger (2016122800401139000_140.1.118.20) 2012; 119 Ayton (2016122800401139000_140.1.118.2) 2014; 2014 2016122800401139000_140.1.118.11 2016122800401139000_140.1.118.55 2016122800401139000_140.1.118.10 2016122800401139000_140.1.118.54 2016122800401139000_140.1.118.53 2016122800401139000_140.1.118.52 2016122800401139000_140.1.118.50 Betts (2016122800401139000_140.1.118.4) 2016; 138 Chen (2016122800401139000_140.1.118.9) 1993; 14 |
References_xml | – volume: 119 start-page: 1523 year: 2012 ident: 2016122800401139000_140.1.118.20 article-title: Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies publication-title: J Neural Transm doi: 10.1007/s00702-012-0873-0 – ident: 2016122800401139000_140.1.118.34 doi: 10.1002/ana.22592 – ident: 2016122800401139000_140.1.118.61 doi: 10.1093/brain/awl388 – volume: 325 start-page: 29 year: 2013 ident: 2016122800401139000_140.1.118.23 article-title: Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy publication-title: J Neurol Sci doi: 10.1016/j.jns.2012.11.009 – ident: 2016122800401139000_140.1.118.63 doi: 10.1371/journal.pone.0112638 – ident: 2016122800401139000_140.1.118.35 doi: 10.1016/j.neuroimage.2012.05.049 – ident: 2016122800401139000_140.1.118.14 doi: 10.1093/brain/114.5.2283 – ident: 2016122800401139000_140.1.118.45 doi: 10.1016/j.neuroimage.2011.02.046 – ident: 2016122800401139000_140.1.118.7 doi: 10.1016/S0197-4580(02)00065-9 – volume: 2014 start-page: 581256 year: 2014 ident: 2016122800401139000_140.1.118.2 article-title: Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration publication-title: Biomed Res Int doi: 10.1155/2014/581256 – ident: 2016122800401139000_140.1.118.11 doi: 10.1016/j.neurobiolaging.2013.09.034 – volume: 29 start-page: 1574 year: 2014 ident: 2016122800401139000_140.1.118.36 article-title: 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease publication-title: Mov Disord doi: 10.1002/mds.26043 – ident: 2016122800401139000_140.1.118.59 doi: 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G – ident: 2016122800401139000_140.1.118.24 doi: 10.1093/brain/aww022 – ident: 2016122800401139000_140.1.118.5 doi: 10.1212/WNL.0b013e31829e6fd2 – volume: 119 start-page: 1515 year: 2012 ident: 2016122800401139000_140.1.118.25 article-title: Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients publication-title: J Neural Transm doi: 10.1007/s00702-012-0898-4 – ident: 2016122800401139000_140.1.118.56 doi: 10.1111/j.1471-4159.1991.tb02017.x – ident: 2016122800401139000_140.1.118.55 doi: 10.1016/j.neuroimage.2008.03.061 – ident: 2016122800401139000_140.1.118.12 doi: 10.1093/brain/114.4.1953 – ident: 2016122800401139000_140.1.118.28 doi: 10.1038/334345a0 – ident: 2016122800401139000_140.1.118.30 doi: 10.1148/radiology.172.2.2748838 – ident: 2016122800401139000_140.1.118.42 doi: 10.1212/01.wnl.0000262033.01945.9a – ident: 2016122800401139000_140.1.118.46 doi: 10.1111/j.1552-6569.2008.00246.x – ident: 2016122800401139000_140.1.118.52 doi: 10.1016/j.neuroimage.2010.10.070 – ident: 2016122800401139000_140.1.118.22 doi: 10.1111/j.1471-4159.1958.tb12607.x – ident: 2016122800401139000_140.1.118.18 doi: 10.1093/brain/122.4.667 – ident: 2016122800401139000_140.1.118.53 doi: 10.1111/j.1471-4159.2010.07132.x – ident: 2016122800401139000_140.1.118.41 doi: 10.3174/ajnr.A4260 – ident: 2016122800401139000_140.1.118.65 doi: 10.1016/j.neuroimage.2013.04.022 – ident: 2016122800401139000_140.1.118.47 doi: 10.1093/brain/awv361 – ident: 2016122800401139000_140.1.118.29 doi: 10.1136/jnnp.55.3.181 – ident: 2016122800401139000_140.1.118.58 doi: 10.1016/j.neuroimage.2014.11.010 – ident: 2016122800401139000_140.1.118.21 doi: 10.1002/nbm.3489 – ident: 2016122800401139000_140.1.118.10 doi: 10.1093/brain/122.8.1437 – ident: 2016122800401139000_140.1.118.49 doi: 10.1111/j.1471-4159.1989.tb09150.x – ident: 2016122800401139000_140.1.118.26 doi: 10.1002/nbm.3554 – volume: 20 start-page: 6048 year: 2000 ident: 2016122800401139000_140.1.118.44 article-title: The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity publication-title: J Neurosci doi: 10.1523/JNEUROSCI.20-16-06048.2000 – ident: 2016122800401139000_140.1.118.6 doi: 10.1016/j.tics.2013.03.003 – ident: 2016122800401139000_140.1.118.17 doi: 10.1016/0006-8993(92)91334-B – ident: 2016122800401139000_140.1.118.60 doi: 10.1016/S1474-4422(14)70117-6 – volume: 138 start-page: 43 year: 2016 ident: 2016122800401139000_140.1.118.4 article-title: High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7 T publication-title: Neuroimage doi: 10.1016/j.neuroimage.2016.05.024 – ident: 2016122800401139000_140.1.118.16 doi: 10.1073/pnas.0911177107 – ident: 2016122800401139000_140.1.118.37 doi: 10.1007/s12640-010-9187-x – ident: 2016122800401139000_140.1.118.33 doi: 10.1016/j.jtemb.2013.09.006 – ident: 2016122800401139000_140.1.118.32 doi: 10.3389/fnins.2012.00171 – volume: 9 start-page: e112512 year: 2014 ident: 2016122800401139000_140.1.118.31 article-title: Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study publication-title: PLoS One doi: 10.1371/journal.pone.0112512 – ident: 2016122800401139000_140.1.118.38 doi: 10.1002/mrm.24272 – ident: 2016122800401139000_140.1.118.39 doi: 10.1212/01.wnl.0000286384.31050.b5 – ident: 2016122800401139000_140.1.118.1 doi: 10.1523/JNEUROSCI.1907-15.2016 – ident: 2016122800401139000_140.1.118.64 doi: 10.1093/brain/aws360 – ident: 2016122800401139000_140.1.118.15 doi: 10.1016/0022-3956(75)90026-6 – volume: 36 start-page: 4407 year: 2015 ident: 2016122800401139000_140.1.118.27 article-title: Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping publication-title: Hum Brain Mapp doi: 10.1002/hbm.22928 – volume: 383 start-page: s94 year: 2014 ident: 2016122800401139000_140.1.118.51 article-title: Nigrosome imaging with T2*-weighted 3T MRI as a diagnostic marker of Parkinson's disease: a case-control and cross-sectional study of diagnostic accuracy publication-title: Lancet doi: 10.1016/S0140-6736(14)60357-3 – ident: 2016122800401139000_140.1.118.57 doi: 10.1016/j.neuroimage.2014.02.026 – ident: 2016122800401139000_140.1.118.19 doi: 10.1002/mrm.10171 – ident: 2016122800401139000_140.1.118.62 doi: 10.1016/j.neuroimage.2014.01.060 – ident: 2016122800401139000_140.1.118.43 doi: 10.1093/brain/awv136 – ident: 2016122800401139000_140.1.118.54 doi: 10.1016/j.neuroimage.2006.02.024 – ident: 2016122800401139000_140.1.118.50 doi: 10.1364/OL.28.001194 – ident: 2016122800401139000_140.1.118.8 doi: 10.1007/s00441-004-0956-9 – volume: 14 start-page: 275 year: 1993 ident: 2016122800401139000_140.1.118.9 article-title: MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease publication-title: AJNR Am J Neuroradiol – ident: 2016122800401139000_140.1.118.13 doi: 10.1371/journal.pone.0035397 – ident: 2016122800401139000_140.1.118.48 doi: 10.1088/0031-9155/54/3/012 – ident: 2016122800401139000_140.1.118.3 doi: 10.1016/j.mri.2015.02.021 – ident: 2016122800401139000_140.1.118.40 doi: 10.1002/ana.1133 |
SSID | ssj0014326 |
Score | 2.5925918 |
Snippet | Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 118 |
SubjectTerms | Aged Cerebellar Nuclei - diagnostic imaging Cerebellar Nuclei - metabolism Female Humans Iron - metabolism Magnetic Resonance Imaging - methods Male Middle Aged Parkinson Disease - diagnostic imaging Parkinson Disease - metabolism Substantia Nigra - diagnostic imaging Substantia Nigra - metabolism |
Title | The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27836833 https://www.proquest.com/docview/1839115331 |
Volume | 140 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1460-2156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014326 issn: 0006-8950 databaseCode: KQ8 dateStart: 19960101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1460-2156 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0014326 issn: 0006-8950 databaseCode: DIK dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1460-2156 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0014326 issn: 0006-8950 databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuiDfLS0bicahM83ScI1u1VKgtl12xt8iTOFzQpmwSrco_4F8zE-cpWqlwiZLIsXc9n2bG82TsLYpsE8RaCxSnoQhSpYVWWoo4cyMdOiDzJkPu7FyerIIv63A9m_0eRS3VFXxMf12ZV_I_VMV3SFfKkv0HyvaT4gu8R_riFSmM1xvTeEcNbgVQpwcqkkr2vcZnrr9vKD9xv6zLJnKlCYK9pDLFKGRgCCGntOc2AywqJ_6avuwRTX1V5w9rTlCRGpsT0gL1TXGoYUslkIouB7sYnB2UN6FLscApUptkQz-pH7AwVWVN4LYV-eC4WtTV9nIc7K_HNgs3GtksjOWzgXQEahtywoht4aYJ4ixbdVsebSW0a-XGX8zfFsZqNpwk3G7nRWoQc51r__xrcrw6PU2WR-vl-4ufghqQkaO-7cZyi932IimpGcbndR8thFqlJ9u8CVzmoFnkwC4x1WiuOaY06sryPrvXnjP4JwuaB2xmNg_ZnbM2kuIR-4bY4SPs8BY7vMh5hx0-xQ6fYIfjNz12PpS8Rc5jtjo-Wh6eiLbJhkj9OKyEknEEgQKljJGpj-qsC7EjnQwyiCIjDWrABrm6BvAyF1SIKjYEKCE9fIDU9Z-wvQ0C6hnjeR5nDnjSz3InCECDNHTgSJXKwEfJO2f73UYlaVuBnhqh_EhsJISfNH84sds6Z-_60Re28so14950e54gayR_l96Yoi4TUv5dOs-4c_bUEqOfiRrMSOX7z2_w9Qt2dwDxS7ZXbWvzClXRCl43IPkDeDGSUA |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+whole-brain+pattern+of+magnetic+susceptibility+perturbations+in+Parkinson%27s+disease&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Acosta-Cabronero%2C+Julio&rft.au=Cardenas-Blanco%2C+Arturo&rft.au=Betts%2C+Matthew+J&rft.au=Butryn%2C+Michaela&rft.date=2017-01-01&rft.eissn=1460-2156&rft.volume=140&rft.issue=1&rft.spage=118&rft.epage=131&rft_id=info:doi/10.1093%2Fbrain%2Faww278&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-8950&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-8950&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-8950&client=summon |